Private Wealth Management Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.6K Sell
48
-19
-28% -$4.14K ﹤0.01% 610
2026
Q2
$13.1K Sell
67
-19
-22% -$3.94K ﹤0.01% 510
2026
Q1
$19.3K Hold
86
– – 0.01% 347
2025
Q4
$20.7K Hold
86
– – 0.01% 317
2025
Q3
$23.5K Hold
86
– – 0.01% 293
2025
Q2
$22.2K Hold
86
– – 0.01% 277
2025
Q1
$19.3K Hold
86
– – 0.01% 303
2024
Q4
$19.7K Hold
86
– – 0.01% 306
2024
Q3
$21K Buy
86
+39
+83% +$8.72K 0.01% 274
2024
Q2
$9K Hold
47
– – ﹤0.01% 472
2024
Q1
$9.31K Hold
47
– – ﹤0.01% 424
2023
Q4
$8.08K Buy
+47
New +$7.22K ﹤0.01% 461

Other funds holding RMD

Private Wealth Management Group's RMD Position: Q3 2026 in Review

Private Wealth Management Group reduced its ResMed (RMD) stake by 28% in Q3 2026, selling an estimated $4.14K and leaving 48 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #610.

Private Wealth Management Group first reported a position in RMD in Q4 2023 and has held it in 12 quarters since. The position peaked at $23.5K in Q3 2025. 535 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Private Wealth Management Group held 48 shares of ResMed worth $10.6K as of Q3 2026.
  • Private Wealth Management Group sold 19 ResMed shares in Q3 2026, an estimated $4.14K.
  • ResMed made up ﹤0.01% of Private Wealth Management Group's portfolio in Q3 2026, its #610 holding.
  • Private Wealth Management Group first reported a position in ResMed in Q4 2023 and has held it in 12 quarters since.
  • Private Wealth Management Group's ResMed position peaked at $23.5K in Q3 2025.
  • 535 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Private Wealth Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.